Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
US8263084B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2008 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Nov 28, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition for treating obesity-related diseases comprising an insulinotropic peptide conjugate, more particularly, to a composition for treating obesity-related diseases comprising a conjugate prepared by covalently linking the insulinotropic peptide with a carrier substance via a non-peptidyl linker, and a method for treating obesity-related diseases by using the same. In particular, the composition for treating obesity-related diseases according to the present invention remarkably improves the efficacy of suppressing food intake and its duration to reduce body weight and body fat, thereby being useful for the treatment of obesity-related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.